Inactive Instrument
Protide Pharmaceuticals, Inc. Share Price
Stocks
PPMD
US74371A1034
Biotechnology & Medical Research
OTC Markets Traded| 1 day | +83.33% |
| Manager | Title | Age | Since |
|---|---|---|---|
Milo R. Polovina
CEO | Chief Executive Officer | 70 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Milo R. Polovina
CHM | Chairman | 70 | 18/02/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +83.33% | +46.67% | - | - | 9L | |
| +0.88% | +1.18% | +40.64% | +74.91% | 6.47TCr | |
| -0.26% | +6.91% | +9.79% | +77.36% | 5.48TCr | |
| +0.47% | +3.52% | +9.71% | +100.95% | 5.35TCr | |
| -1.34% | +3.63% | +26.72% | +49.40% | 4.6TCr | |
| -1.47% | +0.99% | +18.51% | +125.40% | 4.29TCr | |
| -1.12% | +1.46% | +218.69% | +828.23% | 4.01TCr | |
| -2.26% | -2.06% | +15.38% | +45.14% | 3.35TCr | |
| +0.22% | -4.77% | +26.59% | +0.55% | 2.4TCr | |
| +12.10% | +16.60% | +58.50% | +46.15% | 2.37TCr | |
| Average | +9.06% | +2.22% | +47.17% | +149.79% | 4.26TCr | |
| Weighted average by Cap. | +0.30% | +2.59% | +44.40% | +151.27% |
Employees
3
